|
- Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark Our purpose is to drive change to defeat diabetes and other serious chronic diseases
- Our medicines | Diabetes medications | Obesity medication - Novo Nordisk
Patient safety is our top priority, and we are committed to supporting the active fight against falsified Novo Nordisk medicines and other illegal activity in the market
- What we do - Novo Nordisk
Novo Nordisk is a global healthcare company with more than 100 years of innovation and leadership in serious chronic disease treatment
- Who we are - Novo Nordisk
Based on principles established by our founders, the Novo Nordisk Way describes the values and behaviours that inform how we conduct our business It sets the direction for our strategy, decisions and actions and applies to all employees in Novo Nordisk
- Newsroom - Novo Nordisk
Discover the most recent developments, press releases and stories from Novo Nordisk Explore our financial results, innovations and achievements that are shaping the future of healthcare
- News Details - Novo Nordisk
Novo Nordisk Press Release To see all the news please click on the button below
- Press releases - Novo Nordisk
Novo Nordisk's CagriSema associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®
- Our heritage | Novo Nordisk | Driving change
This remarkable love story marked the beginning of Novo Nordisk and set the stage for our life-changing protein-based treatments for people living with serious chronic diseases An unordinary beginning? Of course But when it comes to driving change, there’s no greater power than love
|
|
|